The Use of Topical Hemostatic Agents in Cardiothoracic Surgery

Annals of Thoracic Surgery

Volumn 104, Issue 1, 2017, Pages 353-360

  Bracey, Art ^a   Shander, Aryeh ^b   Aronson, Solomon ^c   Boucher, Bradley A ^d   Calcaterra, Domenico ^e   Chu, Michael W A ^f   Culbertson, Richard ^g   Jabr, Karim ^h   Kehlet, Henrik ⁱ   Lattouf, Omar ^j   Malaisrie, S Chris ^k   Mazer, C David ^l   Oberhoffer, Martin M ^m   Ozawa, Sherri ^b   Price, Theolyn ⁿ   Rosengart, Todd ^a   Spiess, Bruce D ^o   Turchetti, Giuseppe ^p  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b ENGLEWOOD HOSPITAL AND MEDICAL CENTER   (United States)

^c DUKE UNIVERSITY HOSPITAL   (United States)

^d UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^e HENNEPIN COUNTY MEDICAL CENTER   (United States)

^f UNIVERSITY OF WESTERN ONTARIO   (Canada)

^g LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^h Medical Center Navicent Health   (Georgia)

ⁱ UNIVERSITY OF COPENHAGEN   (Denmark)

^j EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k NORTHWESTERN UNIVERSITY   (United States)

^l ST MICHAEL'S HOSPITAL   (Canada)

^m DEPARTMENT OF CARDIOLOGY   (Germany)

ⁿ Penrose Hospital   (United States)

^o VIRGINIA COMMONWEALTH UNIVERSITY MEDICAL CENTER   (United States)

^p SCUOLA SUPERIORE SANT ANNA   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN GLUE; FRESH FROZEN PLASMA; HEMOSTATIC AGENT; RECOMBINANT THROMBIN; THROMBIN;

BLOOD COMPONENT THERAPY; BLOOD TRANSFUSION; EVIDENCE BASED PRACTICE; HUMAN; MEDLINE; OBSERVATIONAL STUDY; OPERATIVE BLOOD LOSS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; THORACIC AORTIC SURGERY; THORAX SURGERY; THROMBOCYTE AGGREGATION; HEART SURGERY; HEMOSTATIC TECHNIQUE; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; BLOOD LOSS, SURGICAL; CARDIAC SURGICAL PROCEDURES; HEMOSTATIC TECHNIQUES; HEMOSTATICS; HUMANS;

EID: 85018802367     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2017.01.096     Document Type: Review

References (55)

1. Samudrala, S., Topical hemostatic agents in surgery: a surgeon's perspective. AORN J 88:Suppl (2008), 2–11.
2. Gabay, M., Boucher, B.A., An essential primer for understanding the role of topical hemostats, surgical sealants, and adhesives for maintaining hemostasis. Pharmacotherapy 33 (2013), 935–955.
3. Levy, J.H., Despotis, G.J., Transfusion and hemostasis in cardiac surgery. Transfusion, 48, 2008, 1.
4. Vander, T.J., Stahl, R.F., Early postoperative care. Edmunds, L.H., (eds.) Cardiac surgery in the adult, 1997, McGraw Hill, New York, 347.
5. Stokes, M.E., Ye, X., Shah, M., et al. Impact of bleeding-related complications and/or blood product transfusions on hospital costs in inpatient surgical patients. BMC Health Serv Res, 11, 2011, 135.
6. Hill, G.E., Frawley, W.H., Griffith, K.E., Forestner, J.E., Minei, J.P., Allogeneic blood transfusion increases the risk of postoperative bacterial infection: a meta-analysis. J Trauma 54 (2003), 908–914.
7. Hendrickson, J.E., Hillyer, C.D., Noninfectious serious hazards of transfusion. Anesth Analg 108 (2009), 759–769.
8. Vamvakas, E.C., Blajchman, M.A., Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Blood 113 (2009), 3406–3417.
9. Shander, A., Hofmann, A., Ozawa, S., et al. Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion 50 (2010), 753–765.
10. Spotnitz, W.D., Burks, S., Hemostats, sealants, and adhesives: components of the surgical toolbox. Transfusion 48 (2008), 1502–1516.
11. Spotnitz, W.D., Burks, S., State-of-the-art review: hemostats, sealants, and adhesives II. Update as well as how and when to use the components of the surgical toolbox. Clin Appl Thomb Hemost 16 (2010), 497–514.
12. Spotnitz, W.D., Hemostats, sealants, and adhesives: a practical guide for the surgeon. Am Surgeon 78 (2012), 1305–1321.
13. Moss R. Management of surgical hemostasis: an independent study guide. 2013. Available at https://www.aorn.org/websitedata/cearticle/pdf_file/13603-0001.pdf. Accessed April 12, 2016.
14. Schreiber, M.A., Neveleff, D.J., Achieving hemostasis with topical hemostats: making clinically and economically appropriate decisions in the surgical and trauma settings. AORN J 94:Suppl (2011), 1–20.
15. Lew, W.K., Weaver, F.A., Clinical use of topical thrombin as a surgical hemostat. Biologics 2 (2008), 593–599.
16. Ortel, T.L., Mercer, M.C., Thames, E.H., Moore, K.D., Lawson, J.H., Immunologic impact and clinical outcomes after surgical exposure to bovine thrombin. Ann Surg 233 (2001), 88–96.
17. Su, Z., Izumi, T., Thames, E.H., Lawson, J.H., Ortel, T.L., Antiphospholipid antibodies after surgical exposure to topical bovine thrombin. J Lab Clin Med 139 (2002), 349–356.
18. Doria, C., Fischer, C.P., Wood, C.G., et al. Phase 3, randomized, double-blind study of plasma-derived human thrombin versus bovine thrombin in achieving hemostasis in patients undergoing surgery. Curr Med Res Opin 24 (2008), 785–794.
19. Bruckner, B., Blau, L., Rodriguez, L., et al. Microporous polysaccharide hemosphere absorbable hemostat use in cardiothoracic surgical procedures. J Cardiothorac Surg, 9, 2014, 134.
20. Zwischenberger, J.B., Brunston, R.L.J., Swann, J.R., Conti, V.R., Comparison of two topical collagen-based hemostatic sponges during cardiothoracic procedures. J Invest Surg 12 (1998), 101–106.
21. Sirlak, M., Eryilmaz, S., Yazicioglu, L., et al. Comparative study of microfibrillar collagen hemostat (Colgel) and oxidized cellulose (Surgicel) in high transfusion-risk cardiac surgery. J Thorac Cardiovasc Surg 126 (2003), 666–670.
22. Natour, E., Suedkamp, M., Dapunt, O.E., Assessment of the effect on blood loss and transfusion requirements when adding a polyethylene glycol sealant to the anastomotic closure of aortic procedures: a case-control analysis of 102 patients undergoing Bentall procedures. J Cardiothorac Surg 7 (2012), 105–110.
23. Coselli, J.S., Bavaria, J.E., Fehrenbacher, J., et al. Prospective randomized study of a protein-based tissue adhesive used as a hemostatic and structural adjunct in cardiac and vascular anastomotic repair procedures. J Am Coll Surg 197 (2003), 243–252.
24. LeMaire, S.A., Ochoa, L.N., Conklin, L.D., et al. Nerve and conduction tissue injury caused by contact with BioGlue. J Surg Res 143 (2007), 286–293.
25. LeMaire, S.A., Schmittling, Z.C., Coselli, J.S., et al. Bioglue surgical adhesive impairs aortic growth and causes anastomotic strictures. Ann Thorac Surg 73 (2002), 1500–1506.
26. Tackett, S.M., Calcaterra, D., Magee, G., Lattouf, O.M., Real-world outcomes of hemostatic matrices in cardiac surgery. J Cardiothorac Vasc Anesth 28 (2014), 1558–1565.
27. Oz, M.C., Cosgrove, D.M., Badduke, B.R., et al. Controlled clinical trial of a novel hemostatic agent in cardiac surgery. Ann Thorac Surg 69 (2000), 1376–1382.
28. Nasso, G., Piancone, F., Bonifazi, R., et al. Prospective, randomized clinical trial of the FloSeal Matrix sealant in cardiac surgery. Ann Thorac Surg 88 (2009), 1520–1526.
29. The CoStasis Multi-Center Collaborative Writing Committee. A novel collagen-based composite offers effective hemostasis for multiple surgical indications: results of a randomized controlled trial. Surgery 129 (2001), 445–450.
30. Alizadeh Ghavidel, A., Mirmesdagh, Y., Samiei, N., Gholampour Dehaki, M., Haemostatic role of TachoSil surgical patch in cardiac surgery. J Cardiovasc Thorac Res 6 (2014), 91–95.
31. Kjaergard, H.K., Trumbull, H.R., Vivostat system autologous fibrin sealant: preliminary study in elective coronary bypass grafting. Ann Thorac Surg 66 (1998), 482–486.
32. Codispoti, M., Mankad, P.S., Significant merits of a fibrin sealant in the presence of coagulopathy following paediatric cardiac surgery: randomised controlled trial. Eur J Cardiothorac Surg 22 (2002), 200–205.
33. Hanks, J.B., Kjaergard, H.K., Hollingsbee, D.A., A comparison of the haemostatic effect of Vivostat patient-derived fibrin sealant with oxidised cellulose (Surgicel) in multiple surgical procedures. Eur Surg Res 35 (2003), 439–444.
34. Christenson, J.T., Kalangos, A., Autologous fibrin glue reinforced by platelets in surgery of ascending aorta. Thorac Cardiovasc Surg 52 (2004), 225–229.
35. Lowe, J., Luber, J., Levitsky, S., et al. Evaluation of the topical hemostatic efficacy and safety of Tisseel VH S/D fibrin sealant compared with currently licensed Tisseel VH in patients undergoing cardiac surgery: a phase 3, randomized, double-blind clinical study. J Cardiovasc Surg 48 (2007), 323–331.
36. Maisano, F., Kjærgård, H.K., Bauernschmitt, R., et al. TachoSil surgical patch versus conventional haemostatic fleece material for control of bleeding in cardiovascular surgery: a randomised controlled trial. Eur J Cardiothorac Surg 36 (2009), 708–714.
37. Minato, N., Katayama, Y., Yunoki, J., Kawasaki, H., Satou, H., Hemostatic effectiveness of a new application method for fibrin glue, the “rub-and-spray method,” in emergency aortic surgery for acute aortic dissection. Ann Thorac Cardiovasc Surg 15 (2009), 265–271.
38. Goerler, H., Oppelt, P., Abel, U., Haverich, A., Safety of the use of Tissucol Duo S in cardiovascular surgery: retrospective analysis of 2149 patients after coronary artery bypass grafting. Eur J Cardiothorac Surg 32 (2007), 560–566.
39. Lamm, P., Adelhard, K., Juchem, G., et al. Fibrin glue in coronary artery bypass grafting operations: casting out the Devil with Beelzebub?. Eur J Cardiothorac 32 (2007), 567–572.
40. Birth, M., Figueras, J., Bernardini, S., et al. Collagen fleece-bound fibrin sealant is not associated with an increased risk of thromboembolic events or major bleeding after its use for haemostasis in surgery: a prospective multicentre surveillance study. Patient Saf Surg, 3, 2009, 13.
41. Fastenau, D.R., McIntyre, J.A., Immunochemical analysis of polyspecific antibodies in patients exposed to bovine fibrin sealant. Ann Thorac Surg 69 (2000), 1867–1872.
42. Scheule, A.M., Beierlein, W., Wendel, H.P., et al. Fibrin sealant, aprotinin, and immune response in children undergoing operations for congenital heart disease. J Thorac Cardiovasc Surg 115 (1998), 883–889.
43. Scheule, A.M., Beierlein, W., Wendel, H.P., et al. Aprotinin in fibrin tissue adhesives induces specific antibody response and increases antibody response of high-dose intravenous application. J Thorac Cardiovasc Surg 118 (1999), 348–353.
44. Shander, A., Hofmann, A., Gombotz, H., Theusinger, O.M., Spahn, D.R., Estimating the cost of blood: past, present, and future directions. Best Pract Res Clin Anaesthesiol 21 (2007), 271–289.
45. Shander, A., Financial and clinical outcomes associated with surgical bleeding complications. Surgery 142:Suppl (2007), 20–25.
46. Spotnitz, W.D., Burks, S., Hemostats, sealants, and adhesives III: a new update as well as cost and regulatory considerations for components of the surgical toolbox. Transfusion 52 (2012), 2243–2255.
47. Tackett, S.M., Sugarman, R., Kreuwel, H.T.C., Alvarez, P., Nasso, G., Hospital economic impact from hemostatic matrix usage in cardiac surgery. J Med Econ 17 (2014), 670–676.
48. Corral, M., Ferko, N., Hollmann, S., Broder, M.S., Chang, E., Health and economic outcomes associated with uncontrolled surgical bleeding: a retrospective analysis of the Premier Perspectives Database. Clinicoecon Outcomes Res 7 (2015), 409–421.
49. Ferraris, V.A., Brown, J.R., Despotis, G.J., et al. 2011 update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg 91 (2011), 944–982.
50. American College of Cardiology Foundation/American Heart Association. Methology manual and policies from the ACCF/AHA task force on practice guidelines. 2010. Available at http://my.americanheart.org/professional/statementsguidelines/policiesdevelopment/development/methodologies-and-policies-from-the-accaha-task-force-on-practice-guidelines_ucm_320470_article.jsp#.vnfaqpmltiu. Accessed December 16, 2015.
51. Lumsden, A.B., Heyman, E.R., Prospective randomized study evaluating an absorbable cyanoacrylate for use in vascular reconstructions. J Vasc Surg 44 (2006), 1002–1009.
52. Brunkwall, J., Ruemenapf, G., Florek, H.J., Lang, W., Schmitz-Rixen, T., A single arm, prospective study of an absorbable cyanoacrylate surgical sealant for use in vascular reconstructions as an adjunct to conventional techniques to achieve haemostasis. J Cardiovasc Surg 48 (2007), 471–476.
53. Glickman, M., Gheissari, A., Money, S., Martin, J., Ballard, J.L., A polymeric sealant inhibits anastomotic suture hole bleeding more rapidly than Gelfoam/thrombin: results of a randomized controlled trial. Arch Surg, 137, 2002, 326.
54. Czerny, M., Verrel, F., Weber, H., et al. Collagen patch coated with fibrin glue components. Treatment of suture hole bleedings in vascular reconstruction. J Cardiovasc Surg 41 (2000), 553–557.
55. Azadani, A.N., Matthews, P.B., Ge, L., et al. Mechanical properties of surgical glues used in aortic root replacement. Ann Thorac Surg 87 (2009), 1154–1160.